Mitochondrial dysfunction: a crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death

Pradeep K Kamat1, Santoshkumar Tota, Rakesh Shukla

  • 1Division of Pharmacology, Central Drug Research Institute, P.O. Box 173, Lucknow (U.P.) 226001, India.

Insights

Okadaic acid (OKA) induces memory loss and neuronal damage by disrupting mitochondrial function. Clinically used drugs like donepezil and memantine effectively prevent these adverse effects, highlighting mitochondria

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Pharmacology

Background:

  • Mitochondrial dysfunction is implicated in neurodegenerative diseases.
  • Okadaic acid (OKA) administration causes memory impairment in rats.
  • The role of mitochondrial function in OKA-induced neurodegeneration is unclear.

Purpose of the Study:

  • To investigate the involvement of mitochondrial dysfunction in OKA-induced memory impairment and neuronal damage.
  • To evaluate the therapeutic potential of donepezil and memantine in mitigating these effects.

Main Methods:

  • Intracerebroventricular (ICV) administration of OKA in rats.
  • Behavioral testing (Morris Water Maze) to assess memory function.
  • Biochemical assays for mitochondrial membrane potential, ATP, reactive oxygen species, lipid peroxidation, and nitrite.
  • Analysis of apoptotic factors (caspase-3, caspase-9) and histopathological examination.
  • Assessment of preventive treatment with donepezil and memantine.

Main Results:

  • OKA treatment led to memory impairment, decreased mitochondrial membrane potential, ATP levels, and mitochondrial activity.
  • Increased Ca(2+), reactive oxygen species, lipid peroxidation, and nitrite were observed in OKA-treated rats.
  • OKA induced apoptotic cell death and histological neuronal damage.
  • Donepezil and memantine significantly attenuated OKA-induced memory deficits, mitochondrial dysfunction, apoptosis, and histological changes.

Conclusions:

  • Mitochondrial dysfunction is a key factor in OKA-induced memory impairment and neuronal damage.
  • Clinically used antidementic drugs demonstrate efficacy in preventing OKA-induced adverse effects at behavioral, cellular, and histological levels.
  • Targeting mitochondrial dysfunction offers a potential therapeutic strategy for neurodegenerative conditions.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...